Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

08. Dezember 2010 08:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Prices Underwritten Offering of Common Stock

CAMBRIDGE, Mass., Dec. 8, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
07. Dezember 2010 16:12 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock

CAMBRIDGE, Mass., Dec. 7, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
06. Dezember 2010 13:56 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the 2010 Deutsche Bank BioFEST

CAMBRIDGE, Mass., Dec. 6, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
02. Dezember 2010 09:13 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Sues Teva for Patent Infringement

CAMBRIDGE, Mass., Dec. 2, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
08. November 2010 13:21 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Nature Biotechnology Publication Demonstrating CHO Cells Can Produce Galactose-Alpha-1,3-Galactose Antigens on Proteins

CAMBRIDGE, Mass., Nov. 8, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs,...
05. November 2010 11:27 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals to Present at the Credit Suisse 2010 Healthcare Conference

CAMBRIDGE, Mass., Nov. 5, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
02. November 2010 11:00 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Receives Four Therapeutic Discovery Project Credits Totaling Nearly $1M

CAMBRIDGE, Mass., Nov. 2, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs,...
01. November 2010 08:30 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Reports Financial Results for the Third Quarter of 2010

CAMBRIDGE, Mass., Nov. 1, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today...
26. Oktober 2010 14:21 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Third Quarter 2010 Financial Results

CAMBRIDGE, Mass., Oct. 26, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, will...
26. Oktober 2010 12:51 ET | Quelle: Momenta Pharmaceuticals

Momenta Pharmaceuticals Announces M118 Selected as a "Top 10 Cardiovascular/Metabolic Projects to Watch" Windhover Expert Panel

CAMBRIDGE, Mass., Oct. 26, 2010 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex mixture drugs,...

Vorherige Seite

Nächste Seite